You are here

Press Releases

September 17, 2020
100-million-plus antigen tests to be shipped by end of fall WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests have reached more than 150 million... Read More
August 20, 2020
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement: “AdvaMed fully supports policies that foster innovation and regulatory flexibility to speed quality tests to patients. This principle is core to the... Read More
August 4, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest data from the association... Read More
July 28, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that shipments of COVID-19 molecular diagnostic tests reached one million per day for the week ending July 24, based on the latest data from the association's... Read More
July 21, 2020
Whitaker Calls National Registry “Crucial Tool” for Federal, State Authorities; Announces More Than 65 Million Tests Shipped Nationwide Since Beginning of Pandemic WASHINGTON, D.C. – In its latest action to help ensure the widespread availability of... Read More
June 9, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today released the following statement from Susan Van Meter, executive director of AdvaMedDx, in response to comments on COVID-19 serology/antibody testing at today’s hearing... Read More
March 20, 2020
WASHINGTON, D.C. – Several diagnostics companies have received or will soon receive FDA Emergency Use Authorizations (EUA) that will provide crucial capacity for the U.S. to significantly ramp up testing for the coronavirus (COVID-19).  “The medical... Read More
March 5, 2020
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate, Leading-edge IVCT Development (... Read More
December 19, 2019
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the broader... Read More
June 28, 2019
LAB Act (H.R. 3584) would delay PAMA reporting period in order to improve data collection process for market-based rates   WASHINGTON, D.C. -- With 53 million Americans facing steep year-over-year cuts to vital clinical diagnostics, the American... Read More

Pages